Actinium Pharmaceuticals, Inc. (ATNM) has 6 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Sept. 4, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 4, 2026 filed Sept. 2, 2026 | Almenoff June Sherie Director | $0 | 45,000 | +200% | Yes | |
|
|
||||||
| Sept. 4, 2026 filed Sept. 2, 2026 | Nicholson, C. David Director | $0 | 157,000 | +200% | No | |
|
|
||||||
| Sept. 4, 2026 filed Sept. 2, 2026 | SETH SANDESH Chief Executive Officer | $0 | 2,911,274 | — | No | |
|
|
||||||
| Sept. 4, 2026 filed Sept. 2, 2026 | Shetty Ajit Director | $0 | 154,000 | +200% | No | |
|
|
||||||
| Sept. 4, 2026 filed Sept. 2, 2026 | Chell Jeffrey W. Director | $0 | 154,000 | +200% | No | |
|
|
||||||
Showing the 5 most recent of 6 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free